Skip to main content
SpringerLink
Log in

Fluoroquinolones linked with myasthenia gravis exacerbation

  • Incidence study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. JONES SC, Sorbello A, Boucher RM.Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA Adverse Event Reporting System and a literature review. Drug Safety 34: 839-847, No. 10, 2011

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fluoroquinolones linked with myasthenia gravis exacerbation. React. Wkly. 1370, 4 (2011). https://doi.org/10.2165/00128415-201113700-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201113700-00008

Keywords

Search

Navigation